190 related articles for article (PubMed ID: 32631391)
1. Dysregulation of cancer genes by recurrent intergenic fusions.
Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ
Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391
[TBL] [Abstract][Full Text] [Related]
2. The landscape of chimeric RNAs in bladder urothelial carcinoma.
Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H
Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082
[TBL] [Abstract][Full Text] [Related]
3.
Panebianco F; Kelly LM; Liu P; Zhong S; Dacic S; Wang X; Singhi AD; Dhir R; Chiosea SI; Kuan SF; Bhargava R; Dabbs D; Trivedi S; Gandhi M; Diaz R; Wald AI; Carty SE; Ferris RL; Lee AV; Nikiforova MN; Nikiforov YE
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2307-2312. PubMed ID: 28193878
[TBL] [Abstract][Full Text] [Related]
4. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
Winnes M; Lissbrant E; Damber JE; Stenman G
Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
[TBL] [Abstract][Full Text] [Related]
6. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
7. High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer.
Smit FP; Salagierski M; Jannink S; Schalken JA
BJU Int; 2013 May; 111(5):836-42. PubMed ID: 23578236
[TBL] [Abstract][Full Text] [Related]
8. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
9. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
[TBL] [Abstract][Full Text] [Related]
10. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.
Li W; Liu Y; Li W; Chen L; Ying J
J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779
[TBL] [Abstract][Full Text] [Related]
11. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
[TBL] [Abstract][Full Text] [Related]
12. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
[TBL] [Abstract][Full Text] [Related]
13. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
14. Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients.
Cai C; Tang Y; Li Y; Chen Y; Tian P; Wang Y; Gong Y; Peng F; Zhang Y; Yu M; Wang K; Zhu J; Lu Y; Huang M
Lung Cancer; 2021 Feb; 152():104-108. PubMed ID: 33444901
[TBL] [Abstract][Full Text] [Related]
15. Overview of Fusion Detection Strategies Using Next-Generation Sequencing.
Schröder J; Kumar A; Wong SQ
Methods Mol Biol; 2019; 1908():125-138. PubMed ID: 30649725
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.
Dehghannasiri R; Freeman DE; Jordanski M; Hsieh GL; Damljanovic A; Lehnert E; Salzman J
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15524-15533. PubMed ID: 31308241
[TBL] [Abstract][Full Text] [Related]
17. Fast and sensitive validation of fusion transcripts in whole-genome sequencing data.
Hafstað V; Häkkinen J; Persson H
BMC Bioinformatics; 2023 Sep; 24(1):359. PubMed ID: 37741966
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.
Kloosterman WP; Coebergh van den Braak RRJ; Pieterse M; van Roosmalen MJ; Sieuwerts AM; Stangl C; Brunekreef R; Lalmahomed ZS; Ooft S; van Galen A; Smid M; Lefebvre A; Zwartkruis F; Martens JWM; Foekens JA; Biermann K; Koudijs MJ; Ijzermans JNM; Voest EE
Cancer Res; 2017 Jul; 77(14):3814-3822. PubMed ID: 28512242
[TBL] [Abstract][Full Text] [Related]
19. Chimeric RNAs generated by intergenic splicing in normal and cancer cells.
Jividen K; Li H
Genes Chromosomes Cancer; 2014 Dec; 53(12):963-71. PubMed ID: 25131334
[TBL] [Abstract][Full Text] [Related]
20. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]